A pioneering company based in Glasgow, Scotland, aims to revolutionise the use of ultrasonic technology in robotic surgery.
Nami Surgical, founded in 2022 by Dr Nico Fenu and Dr Rebecca Cleary, specialises in developing miniaturised ultrasonic devices designed for surgical applications.
Nami’s roots are deeply embedded in the University of Glasgow’s Centre for Medical and Industrial Ultrasonics (C-MIU), where both founders completed their PhDs.
The company is prioritising the advancement of ultrasonic technology in robotic surgery. While ultrasonics have been extensively used in imaging, diagnostics and therapeutic applications, their full potential in robotic surgery remains untapped – a gap that Nami Surgical is determined to bridge.
The company’s precision-driven ultrasonic scalpels, small yet powerful, promise to transform robotic-assisted surgery by offering greater flexibility and accuracy than ever before.
Dr Nico Fenu said: ‘Medical ultrasound was first demonstrated in Glasgow in the 1950s, which led to the first ultrasound device entering clinical service in 1965. Now, Nami Surgical is continuing that innovation from the same city, developing cutting-edge ultrasonic tools just a short distance from where Professor Ian Donald made his ground-breaking contributions.’
One of the significant barriers to the widespread use of ultrasonic scalpels in robotic surgery has been their size and limited dexterity.
Due to design constraints, scalpels often used in laparoscopic procedures have not yet reached their full potential in robotic surgery.
Nami Surgical’s miniaturised ultrasonic scalpels are designed to address these limitations, offering surgeons the precision and flexibility required for minimally invasive procedures.
Commenting on the company’s goals, co-founder Dr Rebecca Cleary said: ‘With our high-performance, miniaturised and dexterous tools, we are breaking down the significant barriers to using ultrasonic scalpels in robotic surgery.
‘With our initial investment round secured, we are ready to collaborate with leading surgical robotics companies to develop a new generation of disruptive ultrasonic tools. We aim to set new standards in robotic surgery, with innovations that will shape the future of the field.’
With the robotic-assisted surgery market currently valued at around $9 billion, Nami Surgical is poised to make a significant impact.
The start-up’s collaboration with key players in the surgical robotics industry aims to bring new advancements to the operating room and push the boundaries of what’s possible in robotic surgery.
For more information about Nami Surgical’s technology and innovations, visit their website.
